Bisphosphonates: atypical fractures?
Prescrire International 18(99): 25
2009
ISSN/ISBN: 1167-7422 PMID: 19396935 Document Number: 631196
A disturbing series of atypical hip fractures in patients receiving long-term bisphosphonate therapy was recently published. An unusual radiological pattern of cortical thickening was sometimes observed.
Document emailed within 1 workday
Related Documents
Lee, P.; Seibel, M.J. 2008: More on atypical fractures of the femoral diaphysis New England Journal of Medicine 359(3): 317; Author Reply 317-318Czerwiński, E. 2011: Atypical subtrochanteric fractures after long-term bisphosphonate therapy Endokrynologia Polska 62(1): 84-87
Luangkittikong, S.; Unnanuntana, A. 2014: Prevalence of atypical femoral fractures in Thai patients at a single institution Journal of the Medical Association of Thailand 97(6): 635-643
Bamrungsong, T.; Pongchaiyakul, C. 2010: Bilateral atypical femoral fractures after long-term alendronate therapy: a case report Journal of the Medical Association of Thailand 93(5): 620-624
Byrd, R.P.; Mirza, S.; Roy, T.M. 1995: Lady Windermere's syndrome: an atypical presentation of an atypical mycobacterium Journal of the Tennessee Medical Association 88(8): 303-305
Lecrubier, Y. 2000: Is amisulpride an 'atypical' atypical antipsychotic agent? International Clinical Psychopharmacology 15(Suppl 4): S21-S26
Bhansali, A.; Singh, R.; Sriraam, M.; Bhadada, S. 2006: Pachydermoperiostitis and bisphosphonates Journal of the Association of Physicians of India 54: 340
Sambrook, P.; Olver, I.; Goss, A. 2006: Bisphosphonates and osteonecrosis of the jaw Australian Family Physician 35(10): 801-803
Rehn, J.; Zifko, B.; Weber, B.G.; Kutscha-Lissberg, E.; Nonnemann, H.C. 1973: I. Elbow fractures in the adult. 2. Fresh fractures. b. Fractures of the olecranon Hefte Zur Unfallheilkunde 114: 46-56
Doogue, M. 2006: Bisphosphonates, osteonecrosis of the jaw, and pharmacovigilance New Zealand Medical Journal 119(1246): U2334
Urade, M. 2007: Bisphosphonates and osteonecrosis of the jaws Clinical Calcium 17(2): 241-248
Vehmanen, L.; Saarto, T. 2010: Bisphosphonates and breast cancer Duodecim; Laaketieteellinen Aikakauskirja 126(10): 1229-1237
Limburg, P.J.; Singh, S. 2013: Bisphosphonates in colorectal cancer Clinical Advances in Hematology and Oncology: H&o 11(6): 372-374
Krebs, A. 1970: Results of simultaneous tests with tuberculin and sensitins from atypical mycobacteria in tuberculosis and diseases caused by atypical mycobacteria Zeitschrift für Erkrankungen der Atmungsorgane Mit Folia Bronchologica 133(1): 118-123
Tsurukami, H. 2017: Acute phase reaction following bisphosphonates Clinical Calcium 27(2): 213-223
2001: Osteoporosis therapy with bisphosphonates. Once weekly is enough MMW Fortschritte der Medizin 143(44): 58
Alexandre, C. 1999: Action of bisphosphonates on malignant osteolysis Presse Medicale 28(28): 1536-1540
Finkelshteyn, A.; Yarom, N. 2017: Drug-induced osteonecrosis of the jaw - not just bisphosphonates Refu'at Ha-Peh Veha-Shinayim 34(1): 32-35; 72
Lüftner, D.; Henschke, P.; Possinger, K. 2007: Clinical value of bisphosphonates in cancer therapy Anticancer Research 27(4a): 1759-1768
Zak, M.; Spina, A.M.; Spinazze, R.P.; Perkinson, W.L.; Spinazze, D.J. 2007: Bisphosphonates and the dental patient: part 1 Compendium of Continuing Education in Dentistry 28(8): 464-468; Quiz: 469-470